» Articles » PMID: 21829705

MyD88 and STING Signaling Pathways Are Required for IRF3-mediated IFN-β Induction in Response to Brucella Abortus Infection

Overview
Journal PLoS One
Date 2011 Aug 11
PMID 21829705
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Type I interferons (IFNs) are cytokines that orchestrate diverse immune responses to viral and bacterial infections. Although typically considered to be most important molecules in response to viruses, type I IFNs are also induced by most, if not all, bacterial pathogens. In this study, we addressed the role of type I IFN signaling during Brucella abortus infection, a facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans. Herein, we have shown that B. abortus induced IFN-β in macrophages and splenocytes. Further, IFN-β induction by Brucella was mediated by IRF3 signaling pathway and activates IFN-stimulated genes via STAT1 phosphorylation. In addition, IFN-β expression induced by Brucella is independent of TLRs and TRIF signaling but MyD88-dependent, a pathway not yet described for Gram-negative bacteria. Furthermore, we have identified Brucella DNA as the major bacterial component to induce IFN-β and our study revealed that this molecule operates through a mechanism dependent on RNA polymerase III to be sensed probably by an unknown receptor via the adaptor molecule STING. Finally, we have demonstrated that IFN-αβR KO mice are more resistant to infection suggesting that type I IFN signaling is detrimental to host control of Brucella. This resistance phenotype is accompanied by increased IFN-γ and NO production by IFN-αβR KO spleen cells and reduced apoptosis.

Citing Articles

ZBP1 senses DNA triggering type I interferon signaling pathway and unfolded protein response activation.

Gomes M, Guimaraes E, Oliveira S Front Immunol. 2025; 15:1511949.

PMID: 39850894 PMC: 11754416. DOI: 10.3389/fimmu.2024.1511949.


Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in immune cells.

Persaud A, Khela J, Fernandes C, Chaphekar D, Burnie J, Tang V J Virol. 2024; 98(5):e0036324.

PMID: 38661384 PMC: 11092368. DOI: 10.1128/jvi.00363-24.


Innate Lymphoid Cells and Interferons Limit Neurologic and Articular Complications of Brucellosis.

Moley C, Chambers C, Dadelahi A, Ponzilacqua-Silva B, Abushahba M, Lacey C Am J Pathol. 2023; 193(9):1170-1184.

PMID: 37263343 PMC: 10477959. DOI: 10.1016/j.ajpath.2023.05.006.


Role of the cGAS/STING pathway in the control of infection acquired through the respiratory route.

Alonso Paiva I, A Santos R, Brito C, Ferrero M, Ortiz Wilczynski J, Carrera Silva E Front Immunol. 2023; 14:1116811.

PMID: 37261352 PMC: 10227575. DOI: 10.3389/fimmu.2023.1116811.


A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infection.

Hedges J, Snyder D, Robison A, Thompson M, Aspelin K, Plewa J Innate Immun. 2023; 29(3-4):45-57.

PMID: 37083049 PMC: 10331211. DOI: 10.1177/17534259231168725.


References
1.
Nagarajan U, Prantner D, Sikes J, Andrews Jr C, Goodwin A, Nagarajan S . Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect Immun. 2008; 76(10):4642-8. PMC: 2546839. DOI: 10.1128/IAI.00629-08. View

2.
Prantner D, Darville T, Nagarajan U . Stimulator of IFN gene is critical for induction of IFN-beta during Chlamydia muridarum infection. J Immunol. 2010; 184(5):2551-60. PMC: 2863030. DOI: 10.4049/jimmunol.0903704. View

3.
Auerbuch V, Brockstedt D, Meyer-Morse N, ORiordan M, Portnoy D . Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med. 2004; 200(4):527-33. PMC: 2211930. DOI: 10.1084/jem.20040976. View

4.
Ishii K, Akira S . Innate immune recognition of, and regulation by, DNA. Trends Immunol. 2006; 27(11):525-32. DOI: 10.1016/j.it.2006.09.002. View

5.
Huang L, Ishii K, Akira S, Aliberti J, Golding B . Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9. J Immunol. 2005; 175(6):3964-70. DOI: 10.4049/jimmunol.175.6.3964. View